Healthcare provider profile · identity verified

Brittany Rumple, NP

Nurse Practitioner · DECATUR, IN · NPI 1831574656

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Potassium Chloride	Potassium Chloride	304	53
Levothyroxine Sodium	Levothyroxine Sodium	288	39
Furosemide	Furosemide	139	31
Metoprolol Succinate	Metoprolol Succinate	136	22
Pantoprazole Sodium	Pantoprazole Sodium	135	34
Omeprazole	Omeprazole	134	19
Losartan Potassium	Losartan Potassium	128	17
Atorvastatin Calcium	Atorvastatin Calcium	115	24
Amlodipine Besylate	Amlodipine Besylate	112	22
Lisinopril	Lisinopril	112	16
Warfarin Sodium	Warfarin Sodium	112	suppressed
Fluticasone Propionate	Fluticasone Propionate	111	44
Metformin Hcl	Metformin Hcl	111	12
Eliquis	Apixaban	106	20
Donepezil Hcl	Donepezil Hcl	98	16
Diclofenac Sodium	Diclofenac Sodium	93	32
Escitalopram Oxalate	Escitalopram Oxalate	93	20
Famotidine	Famotidine	89	18
Gabapentin	Gabapentin	89	24
Allopurinol	Allopurinol	72	14
Januvia	Sitagliptin Phosphate	70	suppressed
Buspirone Hcl	Buspirone Hcl	66	16
Sertraline Hcl	Sertraline Hcl	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Duloxetine Hcl	Duloxetine Hcl	57	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	14
Tamsulosin Hcl	Tamsulosin Hcl	52	suppressed
Cephalexin	Cephalexin	51	32
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	50	25
Metoprolol Tartrate	Metoprolol Tartrate	49	14
Trazodone Hcl	Trazodone Hcl	49	11
Divalproex Sodium	Divalproex Sodium	47	suppressed
Carvedilol	Carvedilol	46	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	21
Hydrochlorothiazide	Hydrochlorothiazide	39	suppressed
Oxcarbazepine	Oxcarbazepine	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	17
Midodrine Hcl	Midodrine Hcl	35	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	33	suppressed
Levofloxacin	Levofloxacin	31	19
Torsemide	Torsemide	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Atenolol	Atenolol	27	suppressed
Diltiazem Hcl	Diltiazem Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Ozempic	Semaglutide	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	12
Meloxicam	Meloxicam	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Alendronate Sodium	Alendronate Sodium	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Novolog Flexpen	Insulin Aspart	21	11
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Gemtesa	Vibegron	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	11
Victoza 3-Pak	Liraglutide	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Baclofen	Baclofen	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	14	suppressed
Erythromycin	Erythromycin Base	14	11
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Risperidone	Risperidone	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Kerendia	Finerenone	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Nuplazid	Pimavanserin Tartrate	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Prednisone	Prednisone	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Metolazone	Metolazone	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error